Skip to the explorer

PatientsCann UK · Patient education

From Seed to Patient: the UK medical cannabis pipeline

Every legal prescription in the UK travels the same route: a controlled growing room, a licensed factory, an accredited laboratory, a border, a specialist clinic and a pharmacy. This explorer walks you through all six stages, compares the seven formats a patient can be prescribed, and shows you how to read the paperwork that proves it.

6 regulated stages 7 patient formats Quality and science inspector

This is education, not medical advice. Onset and duration figures are typical ranges reported for each route. Your own response depends on your dose, your product and your body. Never change how you take your medicine without speaking to your prescriber or pharmacist. See all patient resources

The six stages of a legal UK prescription

Select any stage to open the detail. Each one has its own quality standard and its own regulator, and a batch cannot move forward until the stage before it has been signed off.

Genetics, breeding and GACP cultivation

Where the medicine starts: a known plant, grown the same way every time.

Standard GACPRegulator DEFRA and origin inspectors
What happens here

A licensed grower keeps a small number of mother plants and takes cuttings from them, often through tissue culture, so that every crop is genetically the same plant rather than a new cross. Growing rooms are closed loop: light, temperature, humidity, carbon dioxide and air filtering are all controlled and logged.

  • Mother plant care and cutting or tissue culture cloning
  • Batch to batch genetic stability, checked crop by crop
  • Sealed rooms with filtered air and monitored water feeds
Quality standard

(Good Agricultural and Collection Practice). It sets how the plant is grown, fed, harvested and handled. In practice it means no synthetic pesticides, and soil, water and fertiliser chosen so the plant does not draw heavy metals up into the flower. Where the flower is dispensed as it is, GACP alone is not enough: the maker has to write down the point at which production of the begins, and for whole flower that point is the growing room.

Who regulates it

in the UK, alongside the agricultural inspectors of the country the crop is grown in. Growers are inspected and have to keep records for every batch they release.

One decision sets the whole rulebook

What the crop is going to become decides where pharmaceutical rules start. It is the single most important point in the chain, and the one most often got wrong.

If the flower itself is the medicine
The plant is the active substance
Propagation Cultivation and flowering Harvest, drying, curing Packed flower, dispensed as it is
Annex 2, biological medicines

Nothing downstream can purify or sterilise a dried bud, so quality has to be built in from the cuttings onward. recognises that manufacture can begin at propagation.

If the flower will be extracted
The plant is a starting material
Propagation Cultivation and flowering Harvest and drying Extraction and formulation
Annex 7, herbal starting materials

Here quality is defined later. Extraction, filtering and purification can take impurities out, so the plant is grown under and pharmaceutical rules begin at the processing step.

Why sameness matters

A prescription only works as medicine if the next jar behaves like the last one. Controlled genetics and controlled rooms are what let a pharmacist put a fixed cannabinoid percentage on a label. Illicit supply has none of this: the same street name can be a different plant, grown a different way, with a different strength every time, and nobody has tested it.

Pharmaceutical processing and GMP extraction

The crop becomes a pharmaceutical product in a cleanroom.

Standard EU and UK GMPRegulator MHRA
What happens here

Harvested flower is dried and cured at a set temperature and humidity, then milled to a controlled particle size for vaporising. For oils and cartridges the plant material goes through supercritical carbon dioxide extraction, then winterisation to strip out fats and waxes, with any solvent recovered and accounted for.

  • Controlled drying, curing and precision milling
  • Cold carbon dioxide extraction under pressure
  • Winterisation, filtration and solvent recovery
  • Standardising the extract to a fixed cannabinoid strength
Quality standard

EU and UK (Good Manufacturing Practice). Work happens in cleanrooms with ISO class 5 and class 7 air handling and positive air pressure, so air always flows out of the clean space rather than into it. Every step is written down, signed and traceable to the batch. The rulebook is EudraLex Volume 4: Part I for finished medicines, Part II for active substances, and for medicinal cannabis intended for use as whole flower. sits across all of it.

Who regulates it

The , the UK medicines regulator. A site that makes or releases a medicine for UK patients has to hold and keep its GMP certification through inspection.

Three routes out of the same growing room

Where GACP stops and GMP starts depends on what the batch is going to become. Requirements tighten at every step closer to the patient.

GACP, pre harvestGMP, post harvestGood distribution practice
Bulk flower for extraction
Mother plantsRooting and hardeningLarge scale cultivationFast fan assisted dryingMachine trimmingBulk packaging and shippingExtractionActive ingredientFormulationFilling and packaging

Sold on as feedstock, so the later GMP steps happen at another site.

Extracts, including oils, hash and rosin
Mother plantsRooting and hardeningLarge scale cultivationFast dryingMachine trimmingExtractionActive ingredientFormulationFilling and packagingDistribution

Processing can remove impurities, so the finished extract is standardised before it is filled.

Finished packaged flower (Flos)
Mother plantsRooting and hardeningSmall scale cultivationWet hang harvestSlow cool dryingHand trimmingCuringPackagingDistribution

Covered end to end by GMP Annex 2. The flower itself is the finished medicine, so nothing can be cleaned out of it later.

The paper trail is the product

GACP covers the plant. GMP covers the medicine. That is the real difference between a crop and a prescription: in a GMP site nothing moves without a batch record, and if a problem is found later the batch can be traced back and recalled.

Analytical testing and the Certificate of Analysis

An independent laboratory decides whether the batch is fit to release.

Standard ISO/IEC 17025Regulator Accredited laboratory
What happens here

Samples are taken from across the batch and tested in stages. measures how much of each cannabinoid is present. identifies the smaller compounds, including terpenes and anything left behind by processing.

What gets measured
  • Cannabinoid profile: delta-9-THC, CBD and CBG percentages, against a set tolerance
  • Terpene content, measured rather than estimated
  • Heavy metals: lead, cadmium, mercury and arsenic
  • Microbiology: E. coli, salmonella and aspergillus
  • Mycotoxins, the poisons some moulds leave behind
  • Residual solvents from extraction
Quality standard

accredited laboratories. Accreditation covers the method, the equipment and the people, so the same sample tested twice gives the same answer. The results are written up as a , and the batch is not released until they pass.

See a CoA up close

Tab 3 of this explorer contains a mock Certificate of Analysis you can click through, test panel by test panel, to see what each result actually tells a pharmacist.

Controlled importation and border security

Most UK medical cannabis is imported, and every batch needs its own licence.

Standard Per batch import licenceRegulator Home Office and Border Force
What happens here

The batch travels as a controlled drug. Temperature is monitored and held between 15 and 25 degrees Celsius, packaging is tamper evident, and the shipment is held in secure pharmaceutical storage at each handover point rather than in ordinary freight.

  • Monitored temperature for the whole journey
  • Tamper evident seals, checked on arrival
  • Secure vault storage in transit and named handovers
Licences required

Two, not one. An export authorisation from the country the batch leaves, and a Home Office controlled drug import licence for that individual batch coming into the UK. A licence covers one shipment, so this step repeats every time.

Who regulates it

The Home Office Controlled Drugs Licensing Unit and UK Border Force, working to the Misuse of Drugs Regulations. Paperwork that does not match the shipment stops the shipment.

Where delays come from

Per batch licensing is one of the reasons a named product can be out of stock for weeks even when it exists in a warehouse abroad. Nothing can be shipped early or held in bulk without the licence being in place first.

Specialist prescribing and clinical governance

Only a specialist doctor can start a UK medical cannabis prescription.

Standard Specialist register and MDTRegulator GMC, CQC and NICE
What happens here

You are assessed by a doctor on the specialist register, not by a general practitioner. Your history is then reviewed by a , which agrees whether a cannabis based medicine is reasonable for you and records why.

  • Specialist consultation and full history
  • Multi-disciplinary team review of the case
  • Evidence that at least two licensed treatments were tried first, without enough relief or with side effects you could not live with
  • Agreed starting dose, review dates and safety advice
What you receive

A controlled drug prescription, usually issued electronically as an . It names the exact product, strength and quantity, and it is only valid for the person named on it.

Who regulates it

The for the doctor, the for the clinic, and NICE guidance for the treatment decision itself.

Your record is part of the chain

The clinic notes, the team review and the prescription are what make your possession lawful. That is why we ask patients to keep their clinical letter and dispensing label with their medicine. Our verification guidance sets out exactly what to carry.

Pharmacy dispensing and the journey to your door

The last checks happen at a specialist pharmacy, not at the clinic.

Standard Safe custody and final checkRegulator GPhC
What happens here

The original prescription reaches a registered pharmacy that is set up to handle controlled drugs. Stock is kept in a Home Office approved safe. A registered pharmacist makes the final clinical check, labels the medicine for you by name, and releases it.

  • Prescription received and validated against the register
  • Storage in approved safe custody
  • Final pharmacist check and patient specific labelling
  • Tracked delivery by a licensed secure courier, signed for
What is on the label

Your name, the product, the strength, the quantity, the dose instructions, the pharmacy details and the dispensing date. That label is the single most useful thing you can show if you are ever asked to prove your prescription.

Who regulates it

The registers and inspects the pharmacy and the pharmacist. Controlled drug records are auditable, and every dispensed quantity has to reconcile.

Six stages, one chain

From cutting to courier, every step above is licensed, recorded and inspectable. Keep your medicine in its original container with the label attached, and you are holding the end of that chain.

Seven formats a UK patient can be prescribed

Filter by how quickly a format works, how long it lasts, and whether it is inhaled. Open any card for the full detail on how it is taken, how the body absorbs it, and when a clinician would choose it.

Showing all 7 formats.

Inhaled

Whole flower (Flos)

Dried, milled cannabis flower, prescribed to be vaporised in a medical device. Never smoked.

Onset
1 to 5 minutes
Duration
2 to 4 hours
Inhaled

Metered extract vape cartridges

Pre filled cartridges of distillate or solventless rosin, used with a temperature controlled battery.

Onset
1 to 3 minutes
Duration
2 to 3 hours
Oral, sublingual

Whole plant and distillate oils

Measured liquid extract, held under the tongue before swallowing. The usual baseline medicine.

Onset
30 to 90 minutes
Duration
6 to 8 hours
Oral, solid

Capsules and pastilles

Pre measured solid doses, swallowed. The longest cover of any format, and the slowest to arrive.

Onset
60 to 120 minutes
Duration
6 to 10 hours
Inhaled

Solventless extracts: hash and rosin

Concentrate made from the flower itself by sieving or pressing, with no solvent used. Vaporised, never smoked.

Onset
1 to 5 minutes
Duration
2 to 4 hours
Oromucosal

Standardised oromucosal spray

A metered spray to the inside of the cheek or under the tongue, at a fixed licensed strength.

Onset
15 to 40 minutes
Duration
4 to 6 hours
Rectal or vaginal

Suppositories and pessaries

Solid inserts used when the mouth and lungs are not an option, or when relief is needed in the pelvis.

Onset
15 to 30 minutes
Duration
4 to 8 hours

All seven formats on one timeline

Dashed is the wait. Solid is the expected effect. The axis runs from taking the dose to twelve hours later.

No formats match that search. Clear the box or choose a different filter.

Quality and science inspector

Two tools. First, a mock Certificate of Analysis you can click through panel by panel. Second, a timeline that puts the four main routes side by side so you can see how differently they behave in the body.

Certificate of Analysis

EXAMPLE DOCUMENT · NOT A REAL BATCH · FIELDS REDACTED

Product
Cannabis Flos 20 / 1
Batch number
redacted
Testing laboratory
ISO/IEC 17025 accredited
Release status
Passed for release
Selected test panel

Onset against duration, by route

The dashed section is the wait before you feel anything. The solid bar is roughly how long the effect lasts. Select a route to read the figures.

Waiting for onset Expected effect

Many patients are prescribed two formats: a slow one for baseline cover and a fast one for flare ups. Select a route above to see what that route is usually for. Your own timings also shift with how recently you ate, how deeply you inhale and how long you hold it, and the temperature your device is set to.

Who writes the rules, and who enforces them

No single body decides what a medicine has to be. Three layers sit on top of each other, and the UK layer is the one that inspects the site your prescription came from.

WHOGlobal baseline

World Health Assembly resolution WHA 67.20 commits member states to strong medicines regulation. The WHO publishes good manufacturing practice guidance in its Technical Report Series, and rates national regulators with its Global Benchmarking Tool. Its guidance matters most in countries with no regulator of their own.

WHA 67.20Global Benchmarking ToolTechnical Report Series
ICHHarmonised guidance

The International Council for Harmonisation turns that baseline into guidelines regulators can adopt word for word, so a medicine made in one country can be trusted in another. Its 2008 goal was one quality system covering the whole life of a product, built on risk management and science. The idea underneath is : build quality in, rather than test for it at the end.

Q7 active ingredientsQ8 developmentQ9 risk managementQ10 quality systemQ11 drug substances
MHRAUK enforcement

UK GMP is built on ICH Q7 and enforced by the , the UK's . Other countries do the same through their own regulators, which is why an inspection abroad can be recognised here.

United Kingdom, MHRAEuropean UnionUnited States, FDACanadaAustralia, TGAJapan
The same rules follow the product through its whole life
Research and pre clinicalGood practice
Clinical trialsGCP
Production and quality controlGMP
Authorisation and marketGMP and GDP
Distribution and dispensing
You, and the people you look afterThe point of all of it

Standards referenced on this page: GACP and EU or UK GMP for growing and manufacture, ISO/IEC 17025 for laboratories, Home Office controlled drug licensing for import, and GMC, CQC, GPhC and NICE guidance for prescribing and dispensing.